@Article{Brzezińska-Wcisło2018,
journal="Dermatology Review/Przegląd Dermatologiczny",
issn="0033-2526",
volume="105",
number="1",
year="2018",
title="Androgenetic alopecia. Diagnostic and therapeutic recommendations of the Polish Dermatological Society",
abstract="The main pathogenetic process in androgenetic alopecia is dihydrotestosterone-mediated follicular miniaturization in androgen-dependent scalp areas. Differential diagnosis is complex, especially in women, and covers a broad spectrum of non-cicatricial and cicatricial alopecias, particularly telogen effluvium and frontal fibrosing alopecia. The basic additional diagnostic procedure is trichoscopy. Currently there are two drugs approved for the treatment of androgenetic alopecia: minoxidil (in men and women) and finasteride (in men). However, medical literature indicates significantly more therapeutic options. The article presents algorithms recommended for the management of androgenetic alopecia in women and men.",
author="Brzezińska-Wcisło, Ligia
and Rakowska, Adriana
and Rudnicka, Lidia
and Bergler-Czop, Beata
and Czuwara, Joanna
and Maj, Joanna
and Olszewska, Małgorzata
and Placek, Waldemar
and Reich, Adam
and Zegarska, Barbara",
pages="1--18",
doi="10.5114/dr.2018.74162",
url="http://dx.doi.org/10.5114/dr.2018.74162"
}